Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Hantech Bio-Technology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,382	2,572	2,024	816	-	-
Market Cap Growth	-4.43%	27.10%	148.03%	-	-	-
Enterprise Value	2,211	2,421	2,016	858	-	-
Last Close Price	78.80	81.06	69.64	28.26	-	-
PE Ratio	18.24	16.52	13.66	17.19	-	-
PS Ratio	3.32	3.44	3.24	2.70	-	-
PB Ratio	3.00	3.13	5.04	3.04	-	-
P/TBV Ratio	3.03	3.17	5.13	3.07	-	-
P/FCF Ratio	14.66	20.40	-	-	-	-
P/OCF Ratio	12.90	17.06	10.55	12.92	-	-
EV/Sales Ratio	3.08	3.24	3.23	2.84	-	-
EV/EBITDA Ratio	11.22	10.95	10.17	12.52	-	-
EV/EBIT Ratio	13.54	12.26	10.86	15.10	-	-
EV/FCF Ratio	13.61	19.20	-	-	-	-
Debt / Equity Ratio	0.17	0.19	0.82	0.44	0.81	0.62
Debt / EBITDA Ratio	0.67	0.70	1.61	1.57	2.50	1.05
Debt / FCF Ratio	0.82	1.26	-	-	-	12.59
Net Debt / Equity Ratio	-0.22	-0.27	0.41	0.16	0.33	0.06
Net Debt / EBITDA Ratio	-0.92	-1.01	0.82	0.64	1.15	0.11
Net Debt / FCF Ratio	-1.07	-1.77	-1.60	-2.22	-1.67	1.28
Asset Turnover	0.63	0.73	0.89	0.71	0.70	1.22
Inventory Turnover	5.25	5.87	6.27	6.85	6.66	8.32
Quick Ratio	2.08	2.41	1.14	1.29	1.65	1.50
Current Ratio	2.52	2.78	1.52	1.64	2.01	1.78
Return on Equity (ROE)	16.71%	25.43%	44.04%	20.54%	19.11%	48.28%
Return on Assets (ROA)	8.97%	12.04%	16.53%	8.37%	7.23%	20.84%
Return on Invested Capital (ROIC)	23.59%	27.14%	33.86%	16.46%	16.34%	48.92%
Return on Capital Employed (ROCE)	18.40%	21.30%	26.30%	15.10%	12.90%	31.50%
Earnings Yield	5.56%	6.05%	7.32%	5.82%	-	-
FCF Yield	6.82%	4.90%	-5.04%	-2.41%	-	-
Dividend Yield	3.69%	3.59%	1.00%	2.15%	-	-
Payout Ratio	66.03%	12.47%	11.37%	-	24.75%	6.67%
Buyback Yield / Dilution	-7.18%	-3.38%	-8.45%	-7.98%	-2.60%	-9.89%
Total Shareholder Return	-3.49%	0.20%	-7.45%	-5.83%	-2.60%	-9.89%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.